The seven winners will be invited to present their research on the scene. Foto: DCCC DKD, Rune Borre-Jensen.
Date: 24-05-2023
According to tradition, seven promising young researchers will have the opportunity to take the stage at the Danish Cancer Research Days 2023. Here, they will present their research and receive the "Exceptional Young Scientist Abstract" award.
In a short period of time, the Danish Cancer Research Days has become the event that gathers danish cancer research and creates a common and much needed forum.
When the conference takes place on August 31st and September 1st, the best submitted abstracts from younger researchers will be honoured during the session 'Current Danish Cancer Research in the Spotlight', which takes place on Thursday, August 31st from 12:45 to 14:45.
During this session, seven young researchers will take the main stage to present their research and receive the 'Exceptional Young Scientist Abstract' award. There is great academic distinction in conducting exceptional research within the comprehensive context of the Danish Cancer Research Days. An abstract should encompass all parameters relevant to the broad and national field of cancer research, as well as address the specific academic aspects.
As part of their selection to present on stage, they will undergo a programme with professional research communication coach Marianne Godt Hansen prior to the event. This programme aims to facilitate learning and experiences that can be utilised in their future research careers. And, of course, it is expected that this will result in sharp interdisciplinary communication - to the benefit of both the presenters and the audience on the day.
The session 'Current Danish Cancer Research in the Spotlight' will give the audience insights to the diverse research undertaken by young researchers in Denmark. This research holds the potential to benefit Danish cancer patients in the years to come.
The 7 selected young researchers:
Earlier this year, 197 researchers submitted abstracts for the Danish Cancer Research Days. An interdisciplinary evaluation committee has now reviewed these submissions and decided which seven will receive the prestigious prize.
The seven winners are as follows:
- Mike Bogetofte Barnkob, MD, PhD, Department of Clinical Immunology, Odense University Hospital and Kennedy Institute of Rheumatology, University of Oxford, with the abstract 'From bench to bedside: Developing novel and safe chimeric antigen receptor (CAR) T cell therapy to treat lymphoma patients'
- Sarah Marie Bjørnholt, MD, PhD student, Department of Gynecology and Obstetrics, Aarhus University Hospital, Denmark and Institute of Clinical Medicine, Faculty of Health, Aarhus University, Denmark, with the abstract'Risks and benefits of a national adoption of sentinel node mapping in low and intermediate risk endometrial cancer'
- Neel Maria Helvind, MD, PhD, Department of Plastic Surgery, Copenhagen University Hospital: Herlev and Gentofte, with the abstract 'Stage-specific risk of recurrence and death from melanoma in Denmark from 2008 to 2021: A national observational cohort study of 25,720 stage IA-IV patients'
- Amanda Frydendahl Boll Johansen, MSc, PhD., Department of Molecular Medicine, Aarhus University Hospital, with the abstract 'Circulating tumor DNA detection by whole-genome sequencing enables recurrence prediction in colorectal cancer'
- Lena Saltbæk, MD, PhD, Clinic for Cancer Late Effects, Department of Clinical Oncological, and Palliative Care Unit, Zealand’s University Hospital, with the abstract 'Klinik for Senfølger efter Kræft i Region Sjælland – et års kliniske erfaringer'
('Clinic for late effects of cancer in Region Zealand – one year of clinical experience’) - Lotte Lykke Larsen, Research Assistant, Center for General Practice at Aalborg University, Aalborg, Denmark, with the abstract ‘'Hvordan støtter den praktiserende læge bedst op om kræftpatienter, som også er i en socialt sårbar livssituation'
(How does the general practitioner provide the best support for cancer patients who are also in a socially vulnerable life situation?') - Stine Rauff Søndergaard, PhD student, MD, Department of Oncology, Lillebaelt Hospital - University Hospital of Southern Denmark, Vejle, Denmark, with the abstract 'Shared Decision Making with breast cancer patients - does it work?'
See the entire programme and register for your Danish Cancer Research Days by clicking here.